Skip to main content

Fiscal Wizard · Single-issue tearsheet

ATHE / Jun 21, 2026 Run #7407

ATHE

Alterity Therapeutics Limited

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Composite verdict

B 68.6 / 100
Bullish setup · Trend Following 18 drivers · 2 gates blocking
  • Rate of Change
  • Sushi Roll
  • Vortex Signal
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 37th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 26 signals0% Bear
Momentum Bullish 97Mean-reversion Neutral 52

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety +200%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

37.1 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Margin of Safety 100
Free Cash Flow Yield 0
Greenblatt ROC 76
Return on Equity 25
Return on Capital Employed 75
Asset Turnover 25

Technicals Bullish

100.0 / 100

Bullish setup leads (Rate of Change, Sushi Roll, Vortex Signal); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Rate of Change 94
Vortex Signal 88
Sushi Roll 88

Risk Gates

2 blocking 5 caution

2 guards active, 13 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ATHE.